We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ARDX market cap is 1.5B. The company's latest EPS is USD -0.2839 and P/E is -22.68.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.99M | 44.18M | 11.37M | 22.33M | 56.39M |
| Operating Income | -21.88M | 12.14M | -26.06M | -16.62M | 7.4M |
| Net Income | -22.89M | 10.7M | -26.77M | -17.12M | 6.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.28M | 7.57M | 10.1M | 52.16M | 124.46M |
| Operating Income | -91.26M | -90.78M | -154.35M | -63.76M | -63.28M |
| Net Income | -94.94M | -94.31M | -158.17M | -67.21M | -66.07M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 144.67M | 190.07M | 217.02M | 211.2M | 289.38M |
| Total Liabilities | 77.81M | 91.74M | 91.6M | 88.04M | 98.22M |
| Total Equity | 66.86M | 98.33M | 125.42M | 123.16M | 191.16M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 259.78M | 201.56M | 149.91M | 190.07M | 297.58M |
| Total Liabilities | 73.13M | 75.45M | 67.3M | 91.74M | 130.76M |
| Total Equity | 186.66M | 126.11M | 82.62M | 98.33M | 166.82M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -84.33M | -70.04M | -44.8M | -59.53M | -81M |
| Investing | 16.97M | 18.42M | -9.78M | -68.98M | -101.68M |
| Financing | 56.55M | 75.34M | 50.92M | 62.43M | 120.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -76.48M | -81.44M | -152.55M | -70.04M | -89.72M |
| Investing | 23.37M | -31.44M | 50.95M | 18.42M | -131.25M |
| Financing | 155.48M | 22.78M | 83M | 75.34M | 146.3M |
| Market Cap | 1.5B |
| Price to Earnings Ratio | -22.68 |
| Price to Sales Ratio | 12.04 |
| Price to Cash Ratio | 69.77 |
| Price to Book Ratio | 8.98 |
| Dividend Yield | - |
| Shares Outstanding | 232.69M |
| Average Volume (1 week) | 4.28M |
| Average Volume (1 Month) | 5.08M |
| 52 Week Change | 33.61% |
| 52 Week High | 10.13 |
| 52 Week Low | 3.16 |
| Spread (Intraday) | 0.18 (2.8%) |
| Company Name | Ardelyx Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.ardelyx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
